M&A Transaction Multiples - Agrauxine - Epsilon Research Report

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

__________________________________

This report is accessible on EMAT, the reference database for private company acquisition multiples

► Subscribe to EMAT database

► Sectors covered by our analysts

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

► Buy Full EMAT Report

Price: €120

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

► Example of EMAT Report

EPSILON M&A DEAL REPORT

Transaction Multiples for the Valuation of Private Companies

Consortium led by OTC Asset Management / Agrauxine

No EMAT : 22170

Announced Date : 26/07/2010

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Consortium led by OTC Asset Management

Target : Agrauxine

Country : France

Sector of activity :

Agricultural Sector
Health, Pharmaceuticals & Biotechnology > Biotechnology

Business Description :

Founded in 2002, Agrauxine specializes in bio-control (natural treatment protection of plants), discovering, developing, manufacturing, and marketing crop management products for agricultural and...

Transaction multiples available

	EV/ Sales	EV/ Gross Profit	EV/ EBITDA	EV/ EBIT	Eq/ PBT	P/E	Price to Book	Specific multiple(s)
Historic		-	-	-	-	-		-
Current	-	-	-	-	-	-

Rating :

	Multiple available
n.s.	Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports / sub-sector « Agricultural Sector » = 54
Number of EMAT Reports / sub-sector « Biotechnology » = 14

Example of comparable transactions on EMAT (same sub-sector):

03/06/2010

BeCapital Private Equity

Laboratoires Goëmar

France

22192

03/11/2010

Wilex

Heidelberg Pharma

Germany

21959

Source: Epsilon Research / EMAT